Fair Value Calculator Fair Value Calculator
EN DE

SOLIMAC (SOLIMAC) Fair Value & Analysis

IN · Market cap ₹404M

S SOLIMAC SOLIMAC · BSE
Price₹89.00
Fair Value₹59.23
Upside-33.4%
Quality56/100
Watch SOLIMAC for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹44.42 – ₹74.03

Fair value as of: Jul 6, 2026

From 24 valuation models · updated today

Share price −10.7% over the past month.

Price vs Fair Value (12 months)

₹158.80 ₹75.88 Fair Value ₹59.23 Jun 2025 Jul 2026

12‑month range ₹75.88 – ₹158.80 · fair‑value band ₹44.42 – ₹74.03 · the ₹89.00 price screens above the ₹59.23 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SOLIMAC (SOLIMAC) currently trades at ₹89.00, while our model-based Fair Value estimate is ₹59.23 — implying the stock looks roughly 33.4% overvalued today. We read business quality at 56/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SOLIMAC generated revenue of ₹147M at a net margin of 9.4%. Revenue declined 15.2% year over year. It earns a return on equity of 9.4%. Net debt stands at ₹28.2M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹44.42 (bear case) to ₹74.03 (bull case); at ₹89.00, the current price sits above that range. The share trades about 46% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹147M
Revenue growth (YoY) -15.2%
Net margin 9.4%
Return on equity 9.4%
Free cash flow ₹36.6M FY2026
P/E ratio 30.1
More key figures
Operating margin 14.6%
EPS (TTM) ₹2.96
EPS growth (YoY) -8.9%
Net debt ₹28.2M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SOLIMAC reported revenue of ₹190M in FY2026 versus ₹136M in FY2022, a compound +8.8%/yr. Reported net income was ₹13.5M in FY2026, compounding +6.2%/yr from FY2022.

Revenue +8.8%/yr
FY22 ₹136M
FY23 ₹186M
FY24 ₹208M
FY25 ₹225M
FY26 ₹190M
Net income +6.2%/yr
FY22 ₹10.6M
FY23 ₹16.0M
FY24 ₹18.0M
FY25 ₹23.5M
FY26 ₹13.5M

Is SOLIMAC fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SOLIMAC Fair Value". https://www.fairvalue-calculator.com/stock/SOLIMAC

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SOLIMAC (SOLIMAC) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹59.23 versus a price of ₹89.00 — about −33% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SOLIMAC?
Our model-based fair value for SOLIMAC is ₹59.23 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹89.00.
What is the quality score of SOLIMAC?
SOLIMAC has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SOLIMAC (SOLIMAC)?
SOLIMAC reported trailing-twelve-month revenue of about ₹147M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SOLIMAC?
The net profit margin of SOLIMAC is about 9.4%, meaning it keeps roughly 9.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.